PatchMD Launches New Dopamine Support Patch for Natural Mood and Focus Support
Original Vitamin Patch Pioneer Introduces Comprehensive Dopamine Precursor Formula Backed by Clinical ResearchLas Vegas, NV, Dec. 11, 2025 (GLOBE NEWSWIRE)...
Nutrition
Quantum BioPharma Announces Closing of Private Placement & Provides Corporate Update
Toronto, Ontario--(Newsfile Corp. - December 10, 2025) - Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FSE: 0K91) ("Quantum BioPharma" or...
Stellar Health and CenterLight Healthcare Announce Partnership to Enable Providers And Improve Health Outcomes for New York Seniors
NEW YORK, Dec. 10, 2025 /PRNewswire/ -- Stellar Health, a healthcare technology company focused on revolutionizing value-based care, today announced...
New Research from Shed Reveals How Americans Are Really Trying to Lose Weight
From intermittent fasting to GLP-1s, Americans are rethinking how they lose weight—and what "healthy" really looks likeSALT LAKE CITY, Dec....
Aeroflow Health and Molina Healthcare Break Down Barriers to Nutrition and Diabetes Care in South Carolina
The new partnership expands nutrition counseling and DSME services for Molina Commercial and Medicare members statewide to support long-term health...
PetMeds Announces Holiday Collection: Wellness-Focused Gifts for Pets and the People Who Love Them
DELRAY BEACH, Fla., Dec. 10, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., d/b/a PetMeds and parent company of PetCareRx, (Nasdaq:...
PetMeds Announces Holiday Collection: Wellness-Focused Gifts for Pets and the People Who Love Them
DELRAY BEACH, Fla., Dec. 10, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., d/b/a PetMeds and parent company of PetCareRx, (Nasdaq:...
Barinthus Bio Announces Update on Phase 1 AVALON Clinical Trial of VTP-1000 for the Treatment of Celiac Disease
VTP-1000, an antigen-specific immunotherapy to treat celiac disease, showed a dose-dependent pharmacological effect in the SAD portion of the trialVTP-1000...
Barinthus Bio Announces Update on Phase 1 AVALON Clinical Trial of VTP-1000 for the Treatment of Celiac Disease
VTP-1000, an antigen-specific immunotherapy to treat celiac disease, showed a dose-dependent pharmacological effect in the SAD portion of the trialVTP-1000...
Qualia Life Sciences, Award-Winning Supplement Brand, Celebrates Its 10th Year Anniversary
With Human Studies On Every Formula, Qualia's Industry-Leading Research Standards Are Fueling Innovation and Rapid GrowthCARLSBAD, Calif., Dec. 9, 2025...
Fitasy Unveils Breakthrough Technology Making Custom-Fit 3D Printed Shoes More Accessible and Affordable, Supporting Better Foot Health
Fitasy is set to transform the footwear industry with new technology that democratizes access to custom-fit shoes—improving comfort, reducing waste,...
AIML subsidiary NeuralCloud Solutions Signs Commercial Term Sheet with Culminate H Labs to Deploy MaxYield(TM) and Insight360(TM) into INTRINSICA’s DNA-Guided Biofeedback Wellness Ecosystem
This strengthens NeuralCloud's expansion into the global wellness and B2B health practitioner delivery model with high-fidelity cardiac signal processing and...
Promino Announces Secured Convertible Debenture Offering for Proceeds of up to $1 Million
Burlington, Ontario--(Newsfile Corp. - December 9, 2025) - Promino Nutritional Sciences Inc. (CSE: MUSL) (OTC: MUSLF) (FSE: 93X) ("Promino" or...
Abbott’s Lingo™ Now on Android™, Expanding Access to Real-Time Glucose Data
Lingo, Abbott's first over-the-counter biowearable, expands to Android devicesContinuous glucose monitoring devices help people maintain healthy glucose levels, which are...
Adia Nutrition Inc. Files SEC Form 10 as Strategic Step Toward Full Reporting Status
Winter Park, Florida--(Newsfile Corp. - December 8, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), announced today that, with the assistance...
Remedy’s Nutrition® Launches Cyst-Be-Gone™ — Advanced Herbal Formula to Support Natural Cyst & Tissue Wellness
KEY LARGO, Fla., Dec. 06, 2025 (GLOBE NEWSWIRE) -- Remedy's Nutrition®, a trusted natural supplement company since 1972 and a...
Legend Biotech Highlights New CARVYKTI® Data in Multiple Myeloma and First-in-Human Results from Novel CAR-T Platform in Non-Hodgkin Lymphoma at ASH 2025
Triple-class exposed patients with three prior lines of therapy in CARTITUDE-1 and CARTITUDE-4 achieved a median PFS of 50.4 months...
MENU – ORDER AI Announces Global Expansion with New Multilingual Capabilities, Supporting WHO Guidance on Dietary Needs for GLP-1 Users
New multilingual capabilities expand access to real-time GLP-1 dining guidance as WHO highlights the importance of protein-focused nutrition.BOSTON, Dec. 6,...
Medical Care Technologies Inc. (OTC Pink:MDCE) Closes Reg A – Dilution Ends, Growth Phase Begins
MESA, ARIZONA / ACCESS Newswire / December 5, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE) is pleased to announce...
Biogen and Stoke Therapeutics Present Data that Further Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 2025 American Epilepsy Society (AES) Annual Meeting
—Long-term Phase 1/2a and open label extension (OLE) data for zorevunersen on top of standard of care anti-seizure medicines (ASMs)...